Inside Medicine
Subscribe
Cover photo

What was the biggest story in medicine this week?

A little place to share important articles for the week ending October 31, 2021.

Jeremy Faust

Oct 30, 2021
7

This is a “special” Inside Medicine.

I’m posting this page as a place for people to chime in down below in the comments section. (It’s a little experiment. Let’s see how it goes).

So….

What was the most important piece of medical news or research (Covid-19 or otherwise) that came out this past week (ending Sunday, October 31, 2021)?

To join the conversation, just paste a link and a quick description of your choice and why it matters in the Comments section for everyone to read and follow.

Here’s an example…

💡🗣️ That's it! Join the conversation!

Also, follow me on Twitter, Instagram, and on Facebook and help me share accurate frontline medical information!

📬 Subscribe to Inside Medicine here and get updates from the frontline at least twice per week.

Subscribe for free to Inside MedicineWe go beyond health headlines to find out what really matters.
By subscribing, you agree to share your email address with Jeremy Faust to receive their original content, including promotions. Unsubscribe at any time. Meta will also use your information subject to the Bulletin Terms and Policies
More from Inside Medicine
See all

The Omicron/Nu Covid-19 variant. Here’s what we know, and what we don’t.

We should be concerned, but a porous travel ban makes little sense.
Nov 26, 2021
6

Is your surgeon too tired to operate?

Automobile accidents are common among overworked young doctors.
Jan 17
1

Arizona, California, Washington, Wisconsin appear to have more hospitalized patients than beds. 24 states poised to join them.

Lagging state and federal data paint a far rosier picture than harrowing ground conditions.
Jan 12
29
Comments
Log in with Facebook to comment

7 Comments

  • Author
    Jeremy Faust
    I’ll start! Fluvoxamine: Actual randomized clinical trial data showing it helps Covid-19 patients stay out of the hospital (regular or field hospitalization).
    https://insidemedicine.bulletin.com/399057735019874
    Fluvoxamine: an inexpensive pill that works against Covid-19.
    INSIDEMEDICINE.BULLETIN.COM
    Fluvoxamine: an inexpensive pill that works against Covid-19.
    Fluvoxamine: an inexpensive pill that works against Covid-19.
    1
    •  · 11w
  • Eric Funk
    Not sure if this is the "biggest" story but it was my favorite new data of the week. Some good evidence for this already but further confirmed that vaccination >>> prior COVID infection. https://www.cdc.gov/mmwr/volumes/70/wr/mm7044e1.htm...
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized ...
    CDC.GOV
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized ...
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized ...
    2
    •  · 11w
    • Author
      Jeremy Faust
      Yes this was top of the list for me too, especially given how much (i.e. too much) faith people are putting into “natural immunity”.
      1
      •  · 11w
  • Robert Edmonds
    I am biased but this remains the most important topic to me currently:
    https://www.youtube.com/watch?v=laaL0_xKmmA&t=17746s
    Vaccines and Related Biological Products Advisory Committee – 10/26/2021
    YOUTUBE.COM
    Vaccines and Related Biological Products Advisory Committee – 10/26/2021
    Vaccines and Related Biological Products Advisory Committee – 10/26/2021
    1
    •  · 11w
  • Jeanette Tupper Shearer
    The biggest covid-19 news of the week was the announcement from Rochelle Walensky, director of the Center for Disease Control and Prevention (CDC). Walensaky reported, those who are eligible may now receive any of the three covid-19 vaccines currently …
    See more
    CDC signs off on Moderna and Johnson & Johnson boosters and says people can get a shot different from their original one
    WASHINGTONPOST.COM
    CDC signs off on Moderna and Johnson & Johnson boosters and says people can get a shot different from their original one
    CDC signs off on Moderna and Johnson & Johnson boosters and says people can get a shot different from their original one
    1
    •  · 11w
    • Author
      Jeremy Faust
      Yes it makes sense to give access to all. (I’m skeptical that *everyone* needs a boost, but for those who do, it should be available for all options). Big news.
      1
      •  · 11w
  • Julia Kegg
    This was from a few weeks ago.. the booster being approved for those of us w/ Primary Immuno Deficiency and other specific immuno issues who lack the ability to maintain or even make our own antibodies, to be first to receive “boosters”. Our hope is fo…
    See more
    •  · 9w
Share quoteSelect how you’d like to share below
Share on Facebook
Share to Twitter
Send in Whatsapp
Share on Linkedin
Privacy  ·  Terms  ·  Cookies  ·  © Meta 2022
Discover fresh voices. Tune into new conversations. Browse all publications